Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19... see more

TSXV:VXL - Post Discussion

Vaxil Bio Ltd > Phizer and Moderna expected to earn 32 billion from vaccines
View:
Post by bligicka on Dec 11, 2020 6:43pm

Phizer and Moderna expected to earn 32 billion from vaccines

Such a shame that Goren is so slow to execute ....once in a lifetime opportunity and he's taking an extra 6 weeks to make a new batch of Corvax between experiments.....Shame !!!
Comment by bligicka on Dec 11, 2020 6:59pm
Pfizer vaccine alone will likely end up selling close to $14 billion worth worldwide in 2021, according to Damien Conover, the director of health care equity research and equity strategy at the firm Morningstar. Conover noted that this Morningstar calculation is based on the assumption that the company will manufacture a billion doses of their vaccine, and have it fully approved in the late first ...more  
Comment by bligicka on Dec 13, 2020 10:10am
With all the huge billions at stake you would think big pharma would make a run at Vaxil with a mere 10 million market cap and a novel approach with associated patents ......seems like a good insurance policy for big pharma at a minimum price just in case they are on to something ......
Comment by bigbanktheory on Dec 13, 2020 11:01am
Let's all hope something good will happen soon. Blig, we should be patient. Time will unravel the truth once the mice get what is coming. Glta.
Comment by bligicka on Dec 13, 2020 11:10am
Trying to be patient but l feel Goren should be moving alot more aggressive as this is critical to the company's future with billions at stake .... my fear is after the Army's experiment is over David will move to more delays in manufacturing more Corvax for another set of experiments.... when will they begin to officially start phase 1 trials ???
Comment by saintpeter on Dec 13, 2020 2:48pm
Blig have you every invested in a pharma deal like this before, I know this is my first kick at the cat  we have no idea what goes on in the back ground and I'm sure most of us would like to hear new's  more often like the military just didn't walk up to vxl and say hey you guy's we want to test your stuff on mice this must have involved alot of talking back and forth so ...more  
Comment by bigbanktheory on Dec 13, 2020 4:15pm
Saintpeter, I also was thinking about a possible buy out. Guessing results are positive, and our patents filed I'm guessing about nine months ago, this could get pretty exciting. Not only for shareholders, but for all non shareholders too. Glta
Comment by bligicka on Dec 13, 2020 4:25pm
The market valuation is so cheap it must be very enticing, I'm sure big pharma is keeping a close eye on their progress....the closer they get to a positive conclusion on the vaccine the more likely big pharma will just buy out their competition.....
Comment by saintpeter on Dec 13, 2020 5:13pm
if we come in with some great results our shr price will go up by quite a bit i believe adding to our value and would continue to grow as the price would still be low, easy to run up on lower prices and could easily create a MOMO I have personally seen and been part of a few that went that way and would love to see this go that way insiders won't sell the farm cheap IMO
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities